We further found increased hepatic messenger RNA (mRNA) levels in both mouse and human NAFLD samples for genes associated with membrane remodeling (LPCAT2, cPLA2) and eicosanoid production (ALOX15). The gene discussed is LPCAT2; the disease is metabolic dysfunction-associated steatotic liver disease.